Blackwell Publishing

 

Diabetes, Obesity and Metabolism

Edited by:
R. Donnelly, A. Garber and I. Caterson


ISI Journal Citation Reports® Ranking: 2007: 31/92 (Endocrinology & Metabolism)
Impact Factor: 3.441


The only interdisciplinary journal for high-quality research and reviews in the areas of diabetes, obesity and metabolism.

Diabetes, Obesity & Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems.  'Metabolism' may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter. 

TopNews and Announcements

Free Access in the Developing World
Free online access to this journal is available within institutions in the developing world through the HINARI  initiative with the World Health Organization (WHO). 

Articles published online ahead of print
Articles which have been fully copy-edited and peer-reviewed are published online through our OnlineEarly feature before the print edition of this journal is published.

NIH Public Access Mandate
For those interested in the Wiley-Blackwell policy on the NIH Public Access Mandate,  please visit our policy statement. 

 

TopHighlights